2024 annual financial data
Atara Biotherapeutics 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -53.29%.
Operating income was -83,438,000 USD and net income was -85,403,000 USD.
Operating cash flow was -68,717,000 USD.
Get free Atara Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 128,940,000 USD
- Operating income
- -83,438,000 USD
- Net income
- -85,403,000 USD
- Operating cash flow
- -68,717,000 USD